MA Private Wealth’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-12,700
Closed -$76.1K 69
2023
Q4
$76.1K Buy
+12,700
New +$76.1K 0.02% 76